RAB25 Antibody

1. ZEB2 directly binds to E-box sequences in the RAB25 promoter.ZEB2 stably represses RAB25 expression through epigenetic regulation by SIRT1 during epithelial-to-mesenchymal transition. PMID: 30445998
2. Results indicated that miR-577 suppressed EMT by inhibiting Rab25 expression in breast cancer (BC). MiR-577 and Rab25 are considered potential targets of BC treatment. PMID: 29524309
3. Rab25 is amplified and enhances aggressiveness in luminal B cancers while in claudin-low tumors, Rab25 is lost indicating possible anti-tumor functions PMID: 27259233
4. Our results suggest that Rab25 tumourigenic potential and chemoresistance relies on HIF1 activity in aggressive and metastatic ovarian cancer PMID: 26967059
5. The results from this analysis indicated that Rab11a, Rab11c(Rab25) and Rab14 were expressed in a wide range of cell lines, including the human placental trophoblastic BeWo cell line. PMID: 28922401
6. Data show that Rab25 is responsible for RIN1-induced EGFR signaling and tumor malignancy in clear cell renal cell carcinoma cell. PMID: 28612496
7. Promoter methylation results in downregulation of RAB25 expression in oropharyngeal squamous cell carcinoma. Decreased Rsb25 expression is associated with lymph node metastasis. PMID: 27379752
8. Rab25 may act as a tumor promoter. PMID: 28281975
9. Rab25 was upregulated in hepatocellular carcinoma tissues and cells compared with normal liver tissues and cell lines. Rab25 overexpression correlated with advanced tumor stage and nodal metastasis.Rab25 depletion blocked cell growth rate, inhibited colony formation, downregulated AKT phosphorylation, inhibited the Wnt signaling pathway and its target genes, and negatively regulated the invading ability of HCC cells. PMID: 26692100
10. Rab25 expression is a potential prognostic index for advanced NSCLC patients and its inhibition may improve chemosensitization in NSCLC treatment. PMID: 26535714
11. These results showed that high levels of Rab25 expression were significantly correlated with renal cell carcinoma invasion classification (P < 0.01), lymph-node metastasis (P < 0.001), and pathological stage (P < 0.01). PMID: 25686498
12. High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma. PMID: 24403269
13. the crystal structure of Rab25 in complex with the C-terminal region of FIP2, which consists of a central dimeric FIP2 coiled-coil that mediates a heterotetrameric Rab25-(FIP2)2-Rab25 complex. PMID: 24056041
14. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3beta/Snail signaling. PMID: 23722651
15. These findings suggest that Rab25 plays an important role in tumor migration and metastasis, and that understanding its function may lead to the development of new strategies to prevent metastasis in oral cancer patients. PMID: 23340300
16. Rab25 controls intestinal cell polarity through the regulation of gene expression PMID: 23345591
17. RAB25 has been implicated in various cancers, with reports presenting it as both an oncogene and a tumour-suppressor gene. [Review] PMID: 23176489
18. Studies using lentiviral-based overexpression and suppression systems lent support of Rab25 to function as an important tumor suppressor with both anti-invasive and -angiogenic abilities, through a deregulated FAK-Raf-MEK1/2-ERK signaling pathway. PMID: 22991305
19. data showed Rab25 was highly expressed in all subtypes of epithelial ovarian cancers, and two subtypes of germ cell tumors, but not in sex cord stromal tumors; Rab25 expression was not correlated with peritoneal metastasis of ovarian cancer PMID: 23030522
20. higher level of Rab25 was associated with lymphatic metastasis, specifically in ER and PR-positive breast cancer. PMID: 22644676
21. Rab25 acts predominantly in the small-scale fast recycling within the tips of the cell. Our results further support the idea of Rab25 as a promoter of tumor development PMID: 22613965
22. Rab25 induced the accumulation of glycogen in epithelial cancer cells, a process not previously identified. (RAB25) PMID: 22253197
23. Rab25 effectively differentiates Mullerian carcinomas from malignant mesothelioma PMID: 22249560
24. The present study delineates the fundamental elements of a core promoter structure that will be helpful for future studies regarding the regulation of RAB25 gene. PMID: 21075212
25. Loss of Rab25 is associated with triple-negative breast cancer. PMID: 19795443
26. Rab25 may function as a tumor suppressor in intestinal epithelial cells through regulation of protein trafficking to the cell surface. PMID: 20197623
27. Rab25 signalling pathway plays a role in the regulation of cell proliferation and apoptosis in ovarian cancer cells, which indicates that the Rab25 gene plays a definite role in the development and aggressiveness of human ovarian cancer. PMID: 17393986
28. Rab25 contributes to tumor progression by directing the localization of integrin-recycling vesicles and thereby enhancing the ability of tumor cells to invade the extracellular matrix. PMID: 17925226

Show More

Hide All

HGNC: 18238

OMIM: 612942

KEGG: hsa:57111

STRING: 9606.ENSP00000354376

UniGene: Hs.632469